Novel Purine Nucleoside Analogues for Hematological Malignancies

E-ISSN： 2212-3970|3|2|123-136

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.3, Iss.2, 2008-06, pp. : 123-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab Plus Purine Nucleoside Analogs in the Treatment of Indolent Lymphoid Malignancies

By Robak Tadeusz

American Journal of Cancer, Vol. 4, Iss. 5, 2005-01 ,pp. : 279-292

Adis International

Access to resources Recommend Favorite

Purine Nucleoside Analogues Inhibit the Repair of Radiation-induced Potentially Lethal Damage in Mammalian Cells in Culture

By Nakatsugawa S. Sugahara T. Kumar A.

International Journal of Radiation Biology, Vol. 41, Iss. 3, 1982-06 ,pp. : 343-346

Informa Healthcare

Access to resources Recommend Favorite

Coagulation in Hematological Malignancies

By Falanga Anna Vignoli Alfonso Marchetti Marina

Cancer Investigation, Vol. 27, Iss. 1, 2009-01 ,pp. : 7-16

Informa Healthcare

Access to resources Recommend Favorite

Nanotechnology applications in hematological malignancies (Review)

Oncology Reports, Vol. 34, Iss. 3, 2015-01 ,pp. : 1097-1105

Spandidos Publications

Access to resources Recommend Favorite

Role of mTOR in Hematological Malignancies

Current Cancer Therapy Reviews, Vol. 4, Iss. 3, 2008-08 ,pp. : 211-218

Bentham Science Publishers

Access to resources Recommend Favorite